Anti-third party CD8+ CTLs as potent veto cells:: Coexpression of CD8 and FasL is a prerequisite

被引:83
作者
Reich-Zeliger, S [1 ]
Zhao, Y [1 ]
Krauthgamer, R [1 ]
Bachar-Lustig, E [1 ]
Reisner, Y [1 ]
机构
[1] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel
关键词
D O I
10.1016/S1074-7613(00)00050-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Several bone marrow cells and lymphocyte subpopulations, known as "veto cells," were shown to induce transplantation tolerance across major histocompatibility antigens. Recently, it has been suggested that anti-third party CTLs depleted of alloreactivity are endowed with marked veto activity and therefore might potentially facilitate bone marrow allografting without graft versus host disease (GVHD). The veto mechanism is still obscure. While early studies emphasized the role of CD8-mediated apoptosis, more recent evidence indicates a role for Fas-FasL. In the present study we show, by using blocking anti-CD8 antibody, by generating CTLs from FasL or perforin mutated mice, and by gene transfer of FasL, that the veto activity of anti-third party CD8(+) CTLs is dependent upon the simultaneous expression of both CD8 and FasL.
引用
收藏
页码:507 / 515
页数:9
相关论文
共 56 条
[21]   An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow [J].
George, JF ;
Sweeney, SD ;
Kirklin, JK ;
Simpson, EM ;
Goldstein, DR ;
Thomas, JM .
NATURE MEDICINE, 1998, 4 (03) :333-335
[22]   Cytotoxic T lymphocytes to endogenous mouse retroviruses and mechanisms of retroviral escape [J].
Green, WR .
IMMUNOLOGICAL REVIEWS, 1999, 168 :271-286
[23]   Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: A method to ameliorate graft-versus-host disease and extend the donor pool [J].
Gribben, JG ;
Guinan, EC ;
Boussiotis, VA ;
Ke, XY ;
Linsley, L ;
Sieff, C ;
Gray, GS ;
Freeman, GJ ;
Nadler, LM .
BLOOD, 1996, 87 (11) :4887-4893
[24]   CLONAL DELETION OF POSTTHYMIC T-CELLS - VETO CELLS KILL PRECURSOR CYTOTOXIC LYMPHOCYTES-T [J].
HIRUMA, K ;
NAKAMURA, H ;
HENKART, PA ;
GRESS, RE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (03) :863-868
[25]   Inhibition of death receptor signals by cellular FLIP [J].
Irmler, M ;
Thome, M ;
Hahne, M ;
Schneider, P ;
Hofmann, B ;
Steiner, V ;
Bodmer, JL ;
Schroter, M ;
Burns, K ;
Mattmann, C ;
Rimoldi, D ;
French, LE ;
Tschopp, J .
NATURE, 1997, 388 (6638) :190-195
[26]   CLONE-SPECIFIC T-CELL RECEPTOR ANTAGONISTS OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I RESTRICTED CYTOTOXIC T-CELLS [J].
JAMESON, SC ;
CARBONE, FR ;
BEVAN, MJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (06) :1541-1550
[27]  
KAUFMAN CL, 1994, BLOOD, V84, P2436
[28]  
KIKUYA S, 1988, P NATL ACAD SCI USA, V85, P4824
[29]  
KIYOSHI H, 1992, J EXP MED, V175, P863
[30]  
Korb LC, 1999, J IMMUNOL, V162, P6401